News Alerts

Sri Lanka News Alert

Sri Lanka: Over 80,000 cases of dengue in 2017 /update 1

Officials report 80,732 cases of dengue fever in 2017 as of July 7, including at least 220 deaths; Colombo and Gampaha hit hardest

25 Jul 11:51 AM UTC
TIMEFRAME expected from 7/7/2017, 12:00 AM until 7/9/2017, 11:59 PM (Asia/Colombo). COUNTRY/REGION Sri Lanka

Event

Sri Lanka’s Ministry of Health reported that as of Friday, July 7, 80,732 cases of dengue fever and at least 220 related deaths had been reported in the country since the beginning of the year. These numbers represent a significant jump in the annual number of cases when compared to 2016, when a total of 54,727 cases and 78 deaths were reported for the entire year. Health workers characterized the outbreak as an epidemic and indicated that Colombo and Gampaha were the most impacted areas.

Context

Dengue fever is a mosquito-borne disease mostly found in urban and semi-urban areas. Symptoms of classic dengue fever include fever, headache, muscle and joint pain, fatigue, nausea, and rash. Dengue Hemorrhagic Fever (DHF) is a potentially deadly complication that is characterized by high fever, enlargement of the liver, and hemorrhaging. No specific treatment or vaccine is currently available. Be aware that aspirin and non-steroidal anti-inflammatory drugs (ibuprofen) should be avoided as these drugs may worsen bleeding issues associated with the disease. Patients may be given doses of acetaminophen (paracetamol).

Advice

To minimize the risk of contracting mosquito-borne diseases, use insect repellent, wear covering clothing, and consider sleeping under mosquito netting if in high-risk areas. If you develop a high fever during or after travel in areas affected by dengue, seek immediate medical attention.

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news